Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up?.


Autoria(s): Reck M.; Popat S.; Reinmuth N.; De Ruysscher D.; Kerr K.M.; Peters S.; ESMO Guidelines Working Group
Data(s)

2014

Identificador

http://serval.unil.ch/?id=serval:BIB_F186AA87E909

isbn:1569-8041 (Electronic)

pmid:25115305

doi:10.1093/annonc/mdu199

isiid:000342354800004

Idioma(s)

en

Fonte

Annals of Oncology, vol. 25, no. Suppl 3, pp. iii27-iii39

Palavras-Chave #Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Non-Small-Cell Lung/diagnosis; Carcinoma, Non-Small-Cell Lung/secondary; Combined Modality Therapy; Humans; Lung Neoplasms/diagnosis; Lung Neoplasms/pathology; Maintenance Chemotherapy; Molecular Targeted Therapy; Neoplasm Staging; Palliative Care; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome
Tipo

info:eu-repo/semantics/article

article